SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yihua Xu, Xiaofeng Zhou, Brandon T. Suehs, Abraham G. Hartzema, Michael G. Kahn, Yola Moride, Brian C. Sauer, Qing Liu, Keran Moll, Margaret K. Pasquale, Vinit P. Nair, Andrew Bate, A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance, Drug Safety, 2015,

    CrossRef

  2. 2
    J. H. Holmes, T. E. Elliott, J. S. Brown, M. A. Raebel, A. Davidson, A. F. Nelson, A. Chung, P. La Chance, J. F. Steiner, Clinical research data warehouse governance for distributed research networks in the USA: a systematic review of the literature, Journal of the American Medical Informatics Association, 2014, 21, 4, 730

    CrossRef

  3. 3
    Ameet Sarpatwari, Aaron S. Kesselheim, Bradley A. Malin, Joshua J. Gagne, Sebastian Schneeweiss, Ensuring Patient Privacy in Data Sharing for Postapproval Research, New England Journal of Medicine, 2014, 371, 17, 1644

    CrossRef

  4. 4
    K. B. Filion, D. Chateau, L. E. Targownik, A. Gershon, M. Durand, H. Tamim, G. F. Teare, P. Ravani, P. Ernst, C. R. Dormuth, S. Suissa, C. Dormuth, B. Hemmelgarn, G. Teare, P. Martens, P. Caetano, D. Henry, M. Paterson, J. LeLorier, A. Levy, P. Ernst, R. Platt, I. Sketris, Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis, Gut, 2014, 63, 4, 552

    CrossRef

  5. 5
    Torbjörn Callréus, Pharmacovigilance and Public Health Ethics, Pharmaceutical Medicine, 2013, 27, 3, 157

    CrossRef

  6. 6
    T A Hammad, G A Neyarapally, S Iyasu, J A Staffa, G Dal Pan, The Future of Population-Based Postmarket Drug Risk Assessment: A Regulator's Perspective, Clinical Pharmacology & Therapeutics, 2013, 94, 3
  7. 7
    Sarah L. Cutrona, Sengwee Toh, Aarthi Iyer, Sarah Foy, Gregory W. Daniel, Vinit P. Nair, Daniel Ng, Melissa G. Butler, Denise Boudreau, Susan Forrow, Robert Goldberg, Joel Gore, David McManus, Judith A. Racoosin, Jerry H. Gurwitz, Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program, Pharmacoepidemiology and Drug Safety, 2013, 22, 1
  8. You have free access to this content8
    Lesley H. Curtis, Mark G. Weiner, Denise M. Boudreau, William O. Cooper, Gregory W. Daniel, Vinit P. Nair, Marsha A. Raebel, Nicolas U. Beaulieu, Robert Rosofsky, Tiffany S. Woodworth, Jeffrey S. Brown, Design considerations, architecture, and use of the Mini-Sentinel distributed data system, Pharmacoepidemiology and Drug Safety, 2012, 21,
  9. You have free access to this content9
    Richard Platt, Ryan M. Carnahan, Jeffrey S. Brown, Elizabeth Chrischilles, Lesley H. Curtis, Sean Hennessy, Jennifer C. Nelson, Judith A. Racoosin, Melissa Robb, Sebastian Schneeweiss, Sengwee Toh, Mark G. Weiner, The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction, Pharmacoepidemiology and Drug Safety, 2012, 21,
  10. 10
    Ryan M. Carnahan, Carlos J. Bell, Richard Platt, Active Surveillance: The United States Food and Drug Administration's Sentinel Initiative,